EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development

Jingyuan Tong, Di Wang, Haoze Song, Ting Sun, Yanhong Zhao, Wenjing Gu, Lexuan Lin, Yitong Zhao, Yipeng Liang, Xu Jin, Rongfeng Fu, Mankai Ju und 10 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202505249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jingyuan Tong und 21 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Thrombocythemia, Essential, Hematopoietic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Essential thrombocythemia (ET) includes the JAK2 ‐, CALR ‐, and MPL ‐mutated subtypes, and a triple‐negative (TN) ET subtype, which lacks these canonical drivers. How specific driver mutations affect hematopoietic stem cell (HSC) heterogeneity and their relation to ET pathogenesis remain unclear. Here, by using single‐cell RNA sequencing (scRNA‐seq) combined with driver mutation detection across ET patients, it is found that MPL ‐mutated HSCs exhibited aberrant metabolism, CALR ‐mutated HSCs displayed active cell cycling, while JAK2 V617F ‐mutated HSCs demonstrated enhanced megakaryocyte (Mk) priming capacity and interferon (IFN) response. An HSC subset is identified in TN ET that transcriptionally resembled driver‐mutated HSCs, exhibiting enhanced megakaryocytic priming and proliferative activity. Notably, the frequency of a CXCR4 + HSC subset is reduced across the ET spectrum. Loss of CXCR4 + HSCs skewed lineage differentiation of HSCs toward the myeloid lineage, whereas restoring this subset delayed the onset of ET. Altogether, this study reveals both the shared and distinct molecular features of mutant HSCs in ET and provides novel insights into the pathogenesis and potential therapeutic strategies of ET.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombocythemia, EssentialHematopoietic Stem CellsHumansJanus Kinase 2MutationReceptors, ThrombopoietinSingle-Cell AnalysisMegakaryocytesCell DifferentiationCalreticulin

Stichwörter der Autor:innen

CALRCXCR4MPLessential thrombocythemia (ET)myeloproliferative neoplasms (MPN)scRNA‐seqtriple negative ET

Substanzen

Janus Kinase 2Receptors, ThrombopoietinMPL protein, humanJAK2 protein, humanCALR protein, humanCalreticulin

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.
  • Tianjin Institutes of Health Science, Tianjin, 301600, China.

ORCID-Profile: Lihong Shi

Förderung

  • National Key Research and Development Program of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Clinical Research Fund of National Center for Clinical Medical Research of Hematology Diseases
  • CAMS Innovation Fund for Medical Sciences
  • Foundation of Tianjin Municipal Health Commission
  • Special Research Fund for Central Universities, Peking Union Medical College
  • Tianjin Municipal Science and Technology Commission Grant

Zitieren

APA

Tong, J., Wang, D., Song, H., Sun, T., Zhao, Y., Gu, W., Lin, L., Zhao, Y., Liang, Y., Jin, X., Fu, R., Ju, M., Gao, J., Ma, J., Gao, C., Zhang, A., Xiao, Z., Jiang, E., Yang, R., …, & Shi, L. (2026). Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development. Advanced Science. https://doi.org/10.1002/advs.202505249

Vancouver

Tong J, Wang D, Song H, Sun T, Zhao Y, Gu W, et al. Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development. Advanced Science. 2026. doi:10.1002/advs.202505249

BibTeX
@article{Tong2026,
  author = {Tong, Jingyuan and Wang, Di and Song, Haoze and Sun, Ting and Zhao, Yanhong and Gu, Wenjing and Lin, Lexuan and Zhao, Yitong and Liang, Yipeng and Jin, Xu and Fu, Rongfeng and Ju, Mankai and Gao, Jie and Ma, Jinfa and Gao, Chengjie and Zhang, Anqi and Xiao, Zhijian and Jiang, Erlie and Yang, Renchi and Ma, Shihui and Zhang, Lei and Shi, Lihong},
  title = {Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202505249}
}
Kostenlos starten →